Levofloxin-Natrapharm Indications/Uses

Treatment of respiratory tract infections: Acute bacterial exacerbations of chronic bronchitis susceptible to Staphylococcus aureus (oxacillin-susceptible [methicillin-susceptible] strains), S. pneumoniae, H. influenzae, H. parainfluenzae, or M. catarrhalis); Acute bacterial sinusitis (Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis); Community-acquired pneumonia, susceptible S. aureus (oxacillin-susceptible strains), S pneumoniae (including penicillin-resistant strains [penicillin MIC of 2 mcg/ml or greater]), H. influenzae, H. parainfluenzae, Klebsiella pneumoniae, Legionella pneumophila, M. catarrhalis, Chlamydophila pneumoniae (formerly Chlamydia pneumoniae), or Mycoplasma pneumoniae; Nosocomial pneumonia S. aureus (oxacillin-susceptible strains), S. pneumoniae, H. influenzae, Escherichia coli, K. pneumoniae, P. aeruginosa, or Serratia marcescens). If the infection is known or suspected of being caused by P. aeruginosa, concomitant therapy with an antipseudomonal β-lactam anti-infective is recommended.
Uncomplicated or complicated skin and skin structure infections caused by susceptible S. aureus (oxacillin-susceptible strains), Enterococcus faecalis, S. pyogenes or Proteus mirabilis.
The treatment of mild to moderate uncomplicated urinary tract infections (UTIs) caused by susceptible E. coli, K. pneumoniae or S. saprophyticus.
The treatment of mild to moderate complicated UTIs caused by susceptible E. faecalis, Enterobacter cloacae, E. coli, K. pneumoniae, P. mirabilis or P. aeruginosa, and acute pyelonephritis caused by susceptible E. coli including cases with concurrent bacteremia.
The treatment of chronic prostatitis caused by susceptible E. coli, E. faecalis or S. epidermidis (oxacillin-susceptible strains).
Levofloxacin is used as an alternative for treatment of native or prosthetic valve endocarditis caused by fastidious gram-negative bacilli known as the HACEK group (Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, Haemophilus aphrophilus, H. influenzae, H. parainfluenzae, H. paraphrophilus, Kingella denitrificans, K. kingae).
The treatment of uncomplicated gonorrhea caused by susceptible Neisseria gonorrhoeae.
The treatment of epididymitis most likely caused by sexually transmitted enteric bacteria (e.g., E. coli) or when culture or nucleic acid amplification tests are negative for N. gonorrhoeae.
The treatment of meningitis caused by susceptible organisms (e.g., Rhodococcus equi).